Clinical trial NCT06946017: Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
Official title: Effect of a Fermented Whey and Fiber Supplement on Digestive Comfort of Recreational Athletes With and Without GI Complaints
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Digestive Health
Quality of Life
Keywords: Participants
Healthy subjects
Athlete
Women
Men
Fermented Dairy
Prebiotics
Gut microbiota
Self-reported
GI-tract
Diet
Immune markers
Exercise
Lead sponsor: Arizona State University
Sponsor class: OTHER
Collaborators: name: Friesland Campina
First posted: 2025-04-27
Enrollment: 114
Sex: ALL
Minimum age (years): 18
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Intervention model description: Part I is a crossover design. Part II is a parallel design.
Primary purpose: OTHER

Brief summary: A positive impact of a fermented dairy protein with prebiotic fiber supplement on self-reported GI complaints and wellbeing has been suggested (Wardenaar et al. 2024). The following project aims to further investigate the impact of this supplements in athletes with and without GI complaints in two separate data collections.

Part I of the data collection aims to investigate the impact of this supplement vs. a placebo on carbohydrate malabsorption (as a potential cause for GI distress) in athletes that normally don't identify as having GI complaints (randomized double-blind cross over study design covering a total of 9 weeks, including a 3-week washout period).

Part II of the data collection aims to confirm the earlier found results in the previous study (Wardenaar et al. 2024) in a group athletes self-reporting GI complaints that will be randomized into an intervention group or a placebo group (randomized double-blind parallel study design covering a total of 3 weeks).

Detailed description: A substantial number of athletes suffer from gastro-intestinal (GI) problems, which may impair performance and/or subsequent recovery. Regardless of the prevalence of GI complaints, gut barrier integrity is impaired with high-intensity training. Emerging studies show a positive correlation between the gut microbiome and GI problems and general health and wellbeing.

This project will perform two well-controlled studies:

Part I will be looking into the impact of a 3-week supplementation of fermented dairy protein with prebiotic fiber supplement vs. 3-week supplementation of a control supplement on carbohydrate malabsorption (by means of a lactose tolerance test), Bifidobacterium, GI complaints, general well-being and overall gut microbiota in people screened for not reporting substantial GI complaints while being lactose non-persistent (LNP) and/or being responsive to a lactose tolerance test.

Part II investigates the impact of a 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement vs. a control supplement on GI complaints, Bifidobacterium, general well-being, overall gut microbiota, immune markers, gut redox status, and short chain fatty acids in feces in people screened for reporting substantial GI complaints.

Both study parts include multiple standardized exercise tests before and after each supplementation period (Part I: 4 exercise testing days, Part II: 2 exercise testing days). The participants will come in fasted (after not eating starting 10 pm the night before) and they will perform a 60-minute hiking protocol in a warm environment. After the first-time participants will copy their personal exercise protocol during the following session(s). The exercise exists of hiking on a treadmill in a warm environment (30-35°C), while reaching an exercise intensity of 70% of the subject's VO2 max. Which is an intensity in which the subject has an elevated breathing frequency but is still able to talk.

SCREENING After being eligible on paper (based on the results of an online screening questionnaire) people are invited to sign informed consent via REDCap, a secure, web-based application designed for building and managing online surveys and databases for research studies.

For Part I an addition screening step is included to determine eligibility, including a buccal swab to determine lactose non-persistence (to identify the CC gene), as well as a lactose tolerance test (administration of a dose of 25g of lactose mixed into 250mL, with hydrogen breath measurements at 30-, 60- and 90-minutes after lactose consumption). For Part II no additional screening will be performed.

FAMILIARIZATION VISIT Before performing any exercise, body height and weight, as well as waist and hip circumference will be taken by a research team member, and some additional questions will be asked about exercise and diet habits. After this the participant will perform a maximal exercise test, that will be used to determine the exercise intensity during the following exercise sessions. For this purpose, the Balke protocol will be used and VO2 max will be measured. This test includes a treadmill walking/hiking test including progressive stages where the incline increases each minute (by 1%), but the speed remains 3.3mph.

EXERCISE TEST (PART I and PART II) The treadmill will start at 70% of the final incline determined by the max test and participants will start the speed determined by the familiarization test and will be increased as necessary to achieve a heart rate associated with 70% of the VO2max measured during the familiarization visit using a Balke test. Heart rate and speed will be continuously monitored, when speed needs to be adjusted at a later phase during the protocol (because heart rate is not within the targeted HR-range), this will be registered to allow for exact copying the protocol during the next exercise sessions. The exercise will consist of 60 minutes of steady-state exercise. A rating of perceived exertion (RPE) measure via a BORG visual analog scale will be taken every 10-minutes to ensure participants are maintaining a moderate level activity. Only during Part I participants will receive a feeding after the exercise test. Participants will receive at the end of the exercise test 25g lactose mixed into 250mL water, no food will be provided after the heat stress test, but water can be consumed ad libitum.

PART I This part has a randomized controlled cross-over design: Some of the data collection will take place at home (e.g the collection of stool samples, 1-3 minutes per sample, 4-12 minutes total, and filling out a GSRS questionnaire the day after each exercise test for 1-3 minutes per questionnaire, 4-12 minutes total), as well as the consumption of the intervention product or placebo (1-2 minutes per day, 21-42 minutes total), but the majority of the measurements will be collected at our research facility.

Measurements for different testing days for Part I:

Day ≤0: Screening questionnaire (allowing to select eligible athletes based on the criteria listed in inclusion and exclusion criteria). Sign informed consent, perform exercise test to determine heart rate submax including measuring body composition. Provide instructions and provide stool sample collection materials.

Test Day 0, 21, 42, 63: Fecal swab (for microbiota-redox activity) before arrival; Self-reported digestive comfort, general wellbeing (PHQ. K6, SVS), and dietary questionnaires at arrival. Blood sample is taken based on a finger prick using a lancet method (for SCFA/LBP) before the exercise test followed by the exercise test, and another finger prick (\~150 uL blood for LBP). After the lactose dose is consumed post-exercise, multiple hydrogen breath samples are collected (malabsorption). Hydrogen measurements will be issued at baseline (-60 min), post-exercise (0 min), 30-minutes post-exercise (30 min), 60-minutes post-exercise (60 min), 90-minutes post-exercise (90min), 120-minutes post-exercise (120min) 150-minutes post-exercise (150min), 180-minutes post-exercise (180min), 210-minutes post exercise and 240-minutes post exercise (240min). Hydrogen breath analysis is a minimally invasive procedure which requires the participant to breath normally but exhale into a gas sample bag until the 250mL bag is filled. Prior to taking a hydrogen breath sample, a 10mL mouthwash rinse followed by a rinse with water to prevent bacterial flora from affecting the hydrogen breath measures will be completed before each measure of hydrogen.

Accompanying the hydrogen breath test at 0 min, 60 min, 120 min, 180 min and 240 min, an adjusted GSRS questionnaire will also be given for self-reported digestive comfort during the last 60 minutes.

Test Day 0+1; Day 21+1, Day 42+1, Day 63+1: Before the exercise stress test the regular GSRS will be provided to reflect self-reported digestive comfort during the last week, and a 24-hour after exercise an adjusted GSRS questionnaire will be provided to assess the last 24-h for self-reported digestive comfort.

Research questions for Part I:

Question 1: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement lowers lactose malabsorption reflected by consecutive hydrogen breath measurements compared to a control after 60-minute hiking exercise in the heat.

Question 2: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement increase fecal Bifidobacterium compared to a control.

Question 3: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in GI complaints based on a modified gastro-intestinal symptom rating scale (GSRS) during the lactose tolerance test after 60-minute hiking exercise in the heat.

Question 4: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in general wellbeing (measured via multiple questionnaires) and general gut microbiota.

PART II This part has a randomized controlled parallel design: Some of the data collection will take place at home (e.g the collection of stool samples, 3-6 minutes for two samples a time, 6-12 minutes total, and filling out a GSRS questionnaire the day after each exercise test for 1-3 minutes per questionnaire, 2-6 minutes total), as well as the consumption of the intervention product or placebo (1-2 minutes per day, 21-42 minutes total), but the majority of the measurements will be collected at our research facility.

Measurements for different testing days for Part II:

Screening (Day ≤0): Screening questionnaire (select eligible athletes based on inclusion and exclusion criteria); Sign informed consent, perform exercise test to determine heart rate submax, including measuring body composition. Provide instructions and provide stool sample collection materials.

Baseline (Day 0) and Endpoint (Day 21): Fecal swab (for microbiota-redox activity, SFCA composition) before arrival; Venous blood sample (5 mL to measure TNF-a, CRP, IL-4, IL-6, IL-8, IL-10, MCP-1) and saliva (check swab to measure sIgA, and assessment of flow rate) collection for immune markers; Self-reported digestive comfort, general wellbeing (PHQ. K6, SVS), and dietary questionnaires filled out online. An additional blood sample is taken based on a finger prick using a lancet method (\~250 uL blood to measure SCFA and LBP) before the exercise test followed by the exercise test, and another finger prick (to measure LBP again).

Day 0+1 and Day 21+1: day after exercise stress test: A 24-hour after exercise adjusted GSRS questionnaire will be provided to assess the last 24-h for self-reported digestive comfort.

Research questions for Part II:

Question 5: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement lowers GI complaints based on a modified gastro-intestinal symptom rating scale (GSRS) before, directly after, and 24-hours after 60-minute hiking exercise in the heat compared to a control.

Question 6: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement increase fecal Bifidobacterium compared to a control.

Question 7: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in general wellbeing (measured via multiple questionnaires) and general gut microbiota compared to a control.

Question 8: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in immune markers, gut redox status and fecal short chain fatty acids compared to a control.

Eligibility criteria: Aside from having participants fitting the inclusion and exclusion criteria below, potential participants will be screened using the gastrointestinal symptom rating scale (GSRS). Based on the outcome they will be assigned to the Part I (i.e. no self-reported GI tract issues (GSRS questionnaire score GI complaints, based on GSRS screening with all items scored \<4 (severe) and a total GSRS score ≤25), or Part II (i.e. Severe self-reported GI tract issues (GSRS questionnaire score GI complaints, based on GSRS screening with at least one item scored ≥4 (severe) and a total GSRS score ≥30). If they don't fit these criteria (i.e., having a GSRS score ranging from 26-29) they will be excluded from participation.

Inclusion Criteria:

* Healthy subjects living in the Phoenix area in AZ, USA during the study
* Women/Men aged between 18-50 years (50-50%)
* Recreational competitive and non-competitive athletes (exercise at least 2x per week with a minimal total duration of 2 hours/week)
* BMI value between ≥18.5 and ≤ 30 kg/m2
* No physical limitations due to an injury (i.e., able to perform all activities associated with daily living and exercise in an independent manner).
* Willing to slightly increase their energy intake via a supplement during the study period on daily basis in the morning before breakfast.
* Willing and comfortable to perform multiple physical (stress) tests on a treadmill during the study.
* Participants without any contraindications when scoring the Physical Activity Readiness Questionnaire (PAR-Q+).
* Written informed consent
* For part I: Self-perceived lactose intolerance, and/or omission of dairy products, and/or identifying as Hispanic/Latino or Asian
* For part I: Determined to be lactase non-persistent (LNP) CC genotype by qPCR, and/or positive lactose intolerance test (\>20ppm increase from baseline when 25g of lactose administered)

Exclusion Criteria:

* Users of (sport) supplements containing probiotics and/or prebiotics and those unwilling to temporarily stop use of these supplements at least 3 weeks prior to start of the intervention
* Women who plan to start or stop the use of contraceptives before or during study period
* Women that have additional or worse GI symptoms during their period that can be classified as severe
* Smoking
* Clinical lactose intolerance
* Clinical or self-perceived milk protein allergy
* Diagnosed GI tract disorders or diseases
* Musculoskeletal disorders
* Diagnosed metabolic disorders (such as diabetes)
* Use of any medications known to affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).
* Chronic use of gastric acid suppressing medication or anti-coagulants
* Chronic use of anti-inflammatory medication
* Use of antibiotics the past 0-6 months
* Blood donation in the past 2 months
* (Intending to become) Pregnant/lactating women
* Significant changes in body weight during the past 4 weeks (i.e., due to reduction of body weight through limiting caloric intake, illness,)
* Athletes should not aim to lose bodyweight by reducing energy intake during the study
* For Part I: A hydrogen breath peak of less than 20 ppm over baseline during a lactose tolerance test

Primary outcomes:
measure: Part I: Hydrogen in breath
timeFrame: For 240 minutes post exercise after consuming a bolus of lactose.
measure: Part II: Gastrointestinal Symptoms Rating Scores
timeFrame: For 240 minutes post exercise after consuming a bolus of lactose.
Secondary outcomes:
measure: Part I and Part II: Fecal Bifidobacterium
timeFrame: Stool sample collected at least one day before the test day including the exercise test
Other outcomes:
measure: Part I: Gastrointestinal Symptoms Rating Scores
timeFrame: Covering the last 7 days before each testing day.
measure: Part I and Part II: Self-reported general wellbeing
timeFrame: At each testing day, before the exercise test.
measure: Part I and Part II: Self-reported general wellbeing
timeFrame: At each testing day, before the exercise test.
measure: Part I and Part II: Self-reported general wellbeing
timeFrame: At each testing day, before the exercise test.
measure: Part I and Part II: Gut microbiota composition
timeFrame: Stool sample collected at least one day before the test day including the exercise test.
measure: Part I and Part II: Nutrient intake
timeFrame: At each testing day, within 240 minutes after the exercise test.
measure: Part I and Part II: Diet quality
timeFrame: At each testing day, after the exercise test
measure: Part II: Immune markers
timeFrame: At each testing day, before the exercise test.
measure: Part II: Short chain fatty acids
timeFrame: At each testing day, before the exercise test.
measure: Part II: Gut redox status
timeFrame: Stool sample collected at least one day before the test day including the exercise test.
measure: Part I and II: Gut integrity
timeFrame: Pre and post exercise on a testing day, within 5 minutes before and 5 minutes after the exercise test.
measure: Part I and II: Gastrointestinal Symptoms Rating Scores 24 after exercise
timeFrame: Covering the last 24 hours after the exercise test, the day after the exercise test.
Locations:
city: Phoenix
country: United States
facility: ASU Health Futures Center
state: Arizona
Study officials:
References:
citation: Wardenaar FC, Mohr AE, Ortega-Santos CP, Nyakayiru J, Kersch-Counet C, Chan Y, Clear AM, Kurka J, Schott KD, Seltzer RGN. Explorative Characterization of GI Complaints, General Physical and Mental Wellbeing, and Gut Microbiota in Trained Recreative and Competitive Athletes with or without Self-Reported Gastrointestinal Symptoms. Nutrients. 2024 May 30;16(11):1712. doi: 10.3390/nu16111712.